Active Ingredient History
Enterococcus faecium is a Gram-positive, gamma-hemolytic or non-hemolytic bacterium in the genus Enterococcus. It can be commensal in the gastrointestinal tract of humans and animals, but it may also be pathogenic, causing diseases such as neonatal meningitis or endocarditis. Wikipedia
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Acne Vulgaris (Phase 3)
Air Travel (Phase 2/Phase 3)
Basal Ganglia Diseases (Phase 4)
Brain Diseases (Phase 4)
Bronchopulmonary Dysplasia (Phase 3)
Carcinoma, Transitional Cell (Phase 4)
Central Nervous System Diseases (Phase 4)
Cerebral Ventriculitis (Phase 4)
Colitis, Ulcerative (Early Phase 1)
Crohn Disease (Phase 1/Phase 2)
Diabetes Mellitus, Type 2 (Phase 4)
Gastrointestinal Microbiome (Phase 4)
Hyperoxaluria (Phase 1/Phase 2)
Immunoglobulin Light-chain Amyloidosis (Phase 3)
Irritable Bowel Syndrome (Phase 4)
Movement Disorders (Phase 4)
Nephrolithiasis (Phase 1/Phase 2)
Nervous System Diseases (Phase 4)
Neurodegenerative Diseases (Phase 4)
Parkinson Disease (Phase 4)
Parkinsonian Disorders (Phase 4)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue